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Abstract
Breath analysis is becoming increasingly established as a means of assessing metabolic, biochemical and physiological function in health and disease. The
methods available for these analyses exploit a variety of complex physicochemical principles, but are becoming more easily utilised in the clinical setting.
Whilst some of the factors accounting for the biological variation in breath metabolite concentrations have been clariﬁed, there has been relatively little
work on the dietary factors that may inﬂuence them. In applying breath analysis to the clinical setting, it will be important to consider how these factors
may affect the interpretation of endogenous breath composition. Diet may have complex effects on the generation of breath compounds. These effects may
either be due to a direct impact on metabolism, or because they alter the gastrointestinal ﬂora. Bacteria are a major source of compounds in breath, and
their generation of H2, hydrogen cyanide, aldehydes and alkanes may be an indicator of the health of their host.
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Historical background
The relationship between breath composition and health has
been known for many centuries. More than 2500 years ago,
the Greek physician, Hippocrates of Cos noted the importance
of breath smell in the diagnosis of liver disease, using the term
‘foetor hepaticus’ to describe the characteristic breath odour
associated with liver failure (Treatise on Breath Odour and
Disease, 5th century BC).
The ancient Persian physician and philosopher, Ibn Sina
(Avicenna) wrote that ‘...it is the role of the vital force (breath)
to maintain a perfect equilibrium within the elements of the
body, and between the elements of the body and the environ-
ment’ (The Canon of Medicine, 10th century). An important
environmental determinant of breath composition is diet.
Approximately 40 years ago, Pauling et al.(1) investigated
the relationship between breath composition and diet and
recognised the potential impact of intestinal ﬂora as a contri-
buting factor to breath composition. Individuals were placed
on a deﬁned elemental diet, consisting almost entirely of
small molecules that the authors assumed would be absorbed
from the upper gastrointestinal tract, and that intestinal ﬂora
would be reduced in the lower gastrointestinal tract because
of the lack of nutrients reaching them. Using temperature-
programmed gas–liquid partition chromatography, the quanti-
tative determination of about 250 substances in a sample of
human breath was possible at that time.
Introduction
Today, using exquisitely sensitive analytical techniques, more
than 500 compounds have been reproducibly identiﬁed in
exhaled breath(2), though as many as 3000 different compounds
Abbreviations: ppbv, parts per billion by volume; PTR, proton transfer reaction; SIFT, selected ion ﬂow tube; VOC, volatile organic compounds.
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have been sporadically detected in breath of different individ-
uals(3,4). It is now possible to measure volatile organic com-
pounds (VOC) in breath with great sensitivity (down to parts
per billion by volume; ppbv) and speciﬁcity, using MS and
related analytical methods. As a consequence, breath analysis
now has a number of well-established clinical applications(5)
(Table 1). It also has enormous potential value in metabolic
research, particularly when combined with stable isotope label-
ling. It has, for example, been used in kinetic studies of amino
acid metabolism(6). Breath analysis may also be used for appli-
cations that would otherwise be difﬁcult using other techniques,
for example in the assessment of whole-body oxidative stress(7),
or cholesterol biosynthesis(8). Breath analysis may also be a use-
ful adjunct to blood and faecal analysis in the investigation of
gut microbiota(9). The present review brieﬂy outlines the phys-
iological and dietary factors that may have an important impact
on breath compounds and the methods used for assessing
them, together with the reported concentrations of these com-
pounds in health and disease.
Sources of volatile metabolites in exhaled breath
Volatile metabolites in exhaled breath are derived from several
sources: they may be derived from the environmental inspired
air, from cells, including micro-organisms that are located
throughout the oral/nasal cavities and the pulmonary system,
the upper and lower gastrointestinal tracts and from general
human metabolism (Fig. 1)(10–12). For example, NO is present
Table 1. Established and emerging clinical applications of breath analysis
Breath analysis References
Breath H2 test for carbohydrate metabolism Rumessen et al.
(137); Romagnuolo et al.(138); Eisenmann
et al.(139); Bond & Levitt et al.(140,141)
Breath NO test to monitor therapy for asthma Eisenmann et al.(139); Taylor et al.(142)
Breath CO test for neonatal jaundice Stevenson et al.(143)
Breath test for diagnosis of Helicobacter pylori Romagnuolo et al.(138)
Breath test for heart transplant rejection Phillips et al.(144)
Breath NH3 has been identified as an indicator of the efficacy of renal dialysis Endre et al.
(145); Rolla et al.(146); Narasimhan et al.(147)
Breath H2 and the
13CO2:
12CO2 ratio (following the ingestion of
13C-labelled compounds) as
related to gastric emptying and bowel transit times
Bond & Levitt et al.(141); Braden et al.(148); Rao et al.(149);
Geboes et al.(150)
Hydrogen cyanide is released by the pathogen, Pseudomonas aeruginosa, and the
detection of high concentrations of hydrogen cyanide in breath may be used for the early
detection of bacterial infection of children with cystic fibrosis
Shestivska et al.(151); Carroll et al.(152)
Fig. 1. The complex interactions between diet and expired breath metabolites.
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in trace amounts in atmospheric air and is therefore present in
the inspired air; it is also an important biological mediator in
the vasculature(13), being derived from the action of NO
synthase on the amino acid arginine, and is elaborated at
high concentrations by activated inﬂammatory cells(14). Its
concentrations in expired air can therefore be considerably
higher than in inspired air, and may be derived from several
sources.
Physiological variations in breath composition
Site of exhaled breath sampling
The measured concentrations of several exhaled breath con-
stituents differ signiﬁcantly depending on their site of breath
sampling; whether from the mouth, nose, or the static oral
cavity. Some of these compounds, for example NH3, ethanol
and hydrogen cyanide, are predominantly generated in the oral
cavity in healthy subjects(15,16). Hence oral health, including
periodontal and dental disease, are potential confounding fac-
tors(17). It has been shown that concentrations of some com-
pounds in the exhaled breath, for example NH3 and ethanol,
can be increased by sugar and urea mouth washes(18). Hence,
without careful preparation, mouth production of these and
other compounds can compromise the quantiﬁcation of
endogenous trace compounds present in the alveolar breath.
However, the concentrations of both the urea and sucrose sol-
utions used in these latter studies that proved the enhancement
of NH3 and ethanol levels were greater than normally present
in food and beverages; thus in most situations such severe
enhancements will not occur(18). It is also possible to simul-
taneously monitor mouth and nasal concentrations of breath
compounds to elucidate their source(19). Furthermore, it is
possible to sample end-tidal gas only(20) by physically ﬁltering
out gas from the oral cavity (for example, by using buffered
end-tidal sampling), or by data processing post hoc(20,21).
Determinants of inter-individual and intra-individual variation
Intra-individual studies that have been carried out over about
30 d have revealed the temporal variations in the concen-
trations of several common breath metabolites for several
individuals, including: NH3, acetone, isoprene, ethanol and
acetaldehyde(11,22). Breath NH3, acetone and isoprene concen-
trations were reported to have CV of typically 0·3 over this
period. No obvious correlations were found in the distri-
butions of these particular metabolites, except that the NH3
levels were greatest in the breath of the oldest subjects(22).
In population (inter-individual) studies over a longer time-
frame (6 months), breath methanol levels appeared to have a
log-normal distribution for the study population, and did not
correlate with age, breath ethanol or ethanol consumed in
the previous 24 h; however, there was an inverse correlation
with BMI(23). Breath NH3 increased with age, and a weak
but signiﬁcant correlation between breath propanol and
acetone levels was reported(24). Breath isoprene concentrations
have been studied in healthy schoolchildren between 7 and 18
years of age, and in this group there was a strong positive
association with age(25), possibly related to growth, or steroid
hormone biosynthesis.
Fasting and the acute effects of feeding on breath content
Effects of the fasted or fed state on breath constituents are
complex. Breath acetone, NH3, ethanol, isoprene and metha-
nol have been measured during single exhalations whilst fast-
ing and following feeding with a liquid protein-energy meal(26).
Breath acetone concentrations fell from a maximum during
fasting, reaching their nadir between 4 and 5 h after feeding.
Changes in breath NH3 concentrations were biphasic, possibly
related to changes in portal blood ﬂow, with a rapid fall to
approximately 50 % of their fasting levels before rising to
two or three times their baseline values at 5 h(26). A brief
increase in breath ethanol concentrations was found after feed-
ing, and this is probably related to the ethanol content of some
foods. Subsequently, breath ethanol levels remained low
throughout the experimental period. Isoprene concentrations
did not change signiﬁcantly(26). Levels of breath ethanol
increased if a sweet drink or food had been consumed within
2 h before providing a breath sample, but surprisingly no
increase in breath ethanol was apparent when modest alcohol
consumption had occurred the previous evening. Endogenous
breath ethanol and acetaldehyde levels were not signiﬁcantly
correlated with each other(27). It has recently been reported
that breath hydrogen cyanide may rise following the consump-
tion of food or drink(28).
Effect of exercise and the breath cycle on breath content
Alveolar breath isoprene and methyl acetate have been
reported to increase immediately after moderate exercise,
returning to baseline soon thereafter(29,30). We have recently
reported that breath isoprene concentrations rise rapidly
after commencing exercise, and then decrease during the
period of exercise. Plasma cholesterol levels were not
obviously correlated with isoprene concentration in breath.
Also, isoprene levels were not found to be directly related to
sex, age or BMI in this study of adults(30). The changes in
breath isoprene during exercise have been attributed to
changes in tissue fractional perfusion(31), and the changes in
expiratory breath NO observed during exercise have been
reported to be due to changes in air ﬂow rate, rather than
increased NO production(32). The exercise-related changes in
NH3 concentrations in breath exhaled via the nose appear to
vary with age, with a several-fold increase in concentrations
persisting into the post-exercise period(31). These changes
may be dependent on renal function. Breath composition
changes during the breathing cycle. For example, the variation
observed in breath acetone appears to be dependent on
exhaled volume, but not ﬂow(33).
Molecules directly or indirectly derived from food, beverages
and medicines
Following the ingestion of some compounds, there are wide
inter-individual variations in their appearance in the breath.
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For example, following the ingestion of eucalyptol, a constitu-
ent of proprietary medications, its appearance in breath varies
between 1 and 5 h after ingestion, showing wide inter-subject
variations too(34). Green tea was very effective in reducing
volatile sulfur compounds (hydrogen sulﬁde and methyl sul-
ﬁde) in mouth breath, this being attributed to its disinfectant
properties(35). The kinetics of the acute release of aromas
from food or beverages is complex, being dependent on the
physiological processes involved in swallowing, the lipid con-
tent of the food(36) and the vapour pressure of the com-
pound(37). There are a number of volatile compounds in
food that may rapidly appear in the breath following their
consumption(38–40).
Breath alkanes, smoking, other causes of oxidant stress and
dietary antioxidants
Smoking is known to induce a state of oxidative stress that is
associated with lipid peroxidation(41,42) and has been shown to
be associated with substantial changes in breath compo-
sition(43). Oxidative stress has the potential to damage cells, tis-
sues and organs via the production of reactive oxygen species
such as superoxide, H2O2 and the hydroxyl radical
(44).
Oxidative stress may be estimated through breath measure-
ments of biomarkers that include ethane, ethylene and pen-
tane(45–52). Although these hydrocarbons only represent a
small and possibly variable proportion of the total amount
of peroxidised PUFA, their determination in exhaled breath
enables an assessment of oxidative stress in vivo(53). Do
et al.(54) have previously reported that non-smokers have
very low baseline levels of ethane, whilst ethane production
correlated with active (packs per d) and lifelong (pack-years)
tobacco consumption. Miller et al.(55) have reported similar
ﬁndings and also report that breath ethane concentrations
are related to the time interval between the last cigarette
smoked and breath sampling. Do et al.(54) have also shown
that antioxidant vitamin supplementation resulted in attenu-
ation of smoking-related lipid peroxidation with a signiﬁcant
decrease in breath ethane production. Aghdassi & Allard(45)
assessed oxidative stress using breath alkane output and
other markers of lipid peroxidation in several conditions
associated with inﬂammation, including smoking. Lipid per-
oxidation was signiﬁcantly higher and antioxidant vitamin
status signiﬁcantly lower in smokers compared with non-
smokers. β-Carotene or vitamin E supplementation signiﬁcantly
reduced lipid peroxidation, whilst vitamin C supplementation
had no signiﬁcant effect. These ﬁndings are consistent with
those of Hoshino et al.(56) and Allard et al.(57).
In an animal model of vitamin E deﬁciency, the increased
peroxidation of tissue lipids leads to an increased level of
breath pentane(58). However, in their paper, Gelmont
et al.(58) reported that pentane production was also dependent
on dietary linoleate. Breath pentane in the study animals was
reduced by removal of linoleate from their diet, by starvation,
antibiotic treatment or the addition of vitamin C to their food
or water. Breath pentane was increased by the removal of vita-
min E from the diet. The authors concluded that intestinal
bacteria were a major source of breath pentane in addition
to endogenous membrane lipid peroxidation(58). In recent
studies we have found, using selected ion ﬂow tube
(SIFT)-MS, that breath pentane is elevated in patients with
inﬂammatory bowel disease such as ulcerative colitis(59).
The effects of a restricted-energy diet have also been inves-
tigated in the rat model(60). A signiﬁcant decrease in ethane
generation was found in the rats receiving an energy-restricted
diet compared with those fed ad libitum, supporting the
hypothesis that energy restriction reduces the level of oxidative
stress(61).
Breath pentane is derived from the oxidation of n-3 and n-6
fatty acids which appear to be transferred from mother to fetus
during pregnancy(62). However, in women in their last trime-
ster, who have smoked during pregnancy, it has been reported
that breath ethane was higher than for a control group of non-
smokers, and inversely related to serum vitamin C(63). Dietary
n-3 fatty acid supplementation also appeared to increase lipid
peroxidation as assessed by breath alkane output, and this
was not prevented by co-administration of vitamin E(64).
Dietary studies
The effects of dietary constituents on breath composition
are complex, as alluded to in Fig. 2. The acute effects of
diet on breath have been described brieﬂy above. Medium-
and longer-term effects may be mediated by changes of
ﬂora in the gastrointestinal tract(65,66) and direct or indirect
effects on gastro-caecal transit time(67,68), together with effects
on metabolism, systemic inﬂammation(69–71) and redox
state(72,73).
Effects of macronutrients and dietary energy restriction
High- and low-fat diets. Rosenkranz et al.(74) have
investigated the acute effects of a high-fat meal on
pulmonary function and expiratory NO. They found that a
high-fat meal was associated with increased expiratory NO,
but had no effect on a systemic marker of inﬂammation, or
pulmonary function in normal individuals, and the authors
concluded that a high-fat diet may contribute to
inﬂammation within the airway. Studies in patients with
asthma have found that a diet containing a high n-6:n-3 fatty
acid ratio was associated with worsening of asthma control
and higher concentrations of NO in exhaled breath(75).
Ketogenic diets are high in fat, low in carbohydrate and con-
tain adequate levels of protein. Under these conditions fat is
metabolised in preference to carbohydrates, and ketone bodies
(acetone, acetoacetate and β-hydroxybutyrate) are generated in
the liver, leading to ketosis(76). In these circumstances, expira-
tory breath acetone concentrations are increased substantially.
Even in healthy subjects, breath acetone has been reported to
rise more than ﬁve-fold following a ketogenic diet(77,78). Breath
acetone appears to be indicative of systemic ketosis associated
with a ketogenic diet(77,79). Under certain circumstances
acetone is reduced to isopropanol by hepatic alcohol dehydro-
genase and this then also appears in the breath(80).
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Simple carbohydrates and alcohol. H2 breath tests have been
used for the assessment of carbohydrate malabsorption and
abnormal bacterial colonisation of the gut for many years(81).
Basal breath H2 is dependent on dietary carbohydrate
(82). H2
production in man is primarily dependent upon the delivery
of ingested, fermentable substrates to an abundant intestinal
ﬂora that is normally present only in the colon. In the
normal intestine, more than 99 % of H2 production appears
to be of colonic origin, but small-bowel production may be
increased in a patient with excessive numbers of small-bowel
bacteria. H2 breath tests are based on the fact that there is
no source for H2 gas in humans other than bacterial
metabolism of carbohydrates. Respiratory H2 excretion can
therefore be used as an indicator of intestinal H2 production.
In carbohydrate tolerance tests, different carbohydrates are
administered orally and the concentration of H2 is measured
in expired air. When defective sugar absorption is present,
unabsorbed sugars are available in the colon for bacterial
fermentation(83,84). Approximately 14 % of the total H2
production is excreted by the lungs, and rates of breath H2
excretion and production correlates well(85). Smoking raises
and exercise lowers H2 concentrations and is therefore not
allowed during these tests(85).
Orocaecal transit time is increased in subjects with alcohol-
ism, but it also appears to be increased among individuals who
drink moderate amounts of alcohol as assessed by the H2
breath test(86,87). Clearly, this has the potential to alter the
occurrence of speciﬁc breath constituents and the overall
postprandial breath proﬁle. Alcohol is largely metabolised to
acetaldehyde by dehydrogenase enzymes, leading to the
appearance of high concentrations of acetaldehyde in the
breath after alcohol consumption(88,89). Somatic cells and
microbes representing normal human gut ﬂora are also able
to produce acetaldehyde from ethanol(90). After the ingestion
of alcoholic beverages, there are high local acetaldehyde con-
centrations in the saliva, gastric juice and the contents of the
large intestine. In addition, microbes may produce acet-
aldehyde endogenously in the absence of exogenous alcohol
administration(90).
Complex carbohydrates and fibre. Complex carbohydrate and
ﬁbre increase gut transit time and therefore increase the quantity
of fermentable, non-absorbed carbohydrate reaching the distal
intestine, and hence increase the production of gut-derived H2
and CH4
(91–93). In some groups of subjects, there appears to
be an adaptation to high intakes of resistant starch over time
and an apparent relationship with insulin sensitivity(94). Using
breath H2 analysis, Strocchi & Levitt
(95) found that 5–10 % of
starch in wheat, potatoes and maize is not absorbed by healthy
subjects, while rice starch is nearly completely absorbed. The
physiological effects of dietary ﬁbre are not always predictable
Fig. 2. Dietary and metabolic sources of the major metabolites in human breath. GI, gastrointestinal; F1P, fructose 1-phosphate; G6P, glucose 6-phosphate; G1P,
glucose 1-phosphate; LCFA, long-chain fatty acids; BCFA, branched-chain fatty acids; HMG, hydroxy methyl glutaryl; carbomyl P, carbomyl phosphate. The grey
boxes represent compounds that have been identified in breath.
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from their physicochemical properties(96). For example, maize
ﬁbre has been reported to resist fermentation better than
potato ﬁbre and to have a lower digestibility(96). However,
both dietary ﬁbres increased faecal output of DM, neutral
sugars and water. Orocaecal transit time is increased by
potato ﬁbre, and it is reported to reduce postprandial plasma
levels of total and esteriﬁed cholesterol. In contrast, maize
ﬁbre has been reported to lower fasting blood cholesterol
concentrations and increase the non-esteriﬁed cholesterol ratio.
A class of non-digestible but fermentable oligosaccharides,
trans-galacto-oligosaccharides, was found to increase the
concentration of breath H2 and the N density of the
faeces(97), whilst dietary ﬁbre from maize, cassava and
amaranth all increased faecal energy loss. Expired breath H2
was highest for those individuals consuming maize or
cassava(98). In critically ill patients receiving jejunal feeding
with a semi-elemental diet, ﬁbre supplementation appeared
to improve microbiota mass and function, being associated
with increased carbohydrate fermentation, measured as
breath H2 and CH4
(99).
Protein. The ingestion of a high protein-energy meal is
associated with some complex changes in breath
compounds; the changes in exhaled acetone, NH3 and
ethanol concentrations(26) have been discussed above.
Effects of entire diets. A diet that is chronically energy
restricted is associated with longevity, which is probably
related to a reduction in oxidant stress(100,101); such a diet is
also associated with low breath ethane concentrations, that
again may relate to reduced oxidant stress(102).
Kundu et al. have found that the amount of breath acetone
in exhaled breath was correlated with the rate of fat loss(103) in
subjects on a restricted-energy weight-loss programme.
Using a randomised controlled design of the effects of a diet
rich in fruit and vegetables, with or without low-fat dairy pro-
ducts for 8 weeks’ duration, Miller et al.(104) found that breath
ethane was signiﬁcantly reduced in patients on both fruit- and
vegetable-rich diets, but particularly in subjects on a low-fat
dairy diet. The endogenous production of methanol is
increased after the consumption of fruit(105), its concentrations
increasing by as much as an order of magnitude. This is
thought to be due to the degradation of natural pectin
(which is esteriﬁed with methyl alcohol) in the colon. In vivo
studies showed that pectin in either a pure form (10 to 15 g)
or a natural form (in 1 kg of apples) induces a signiﬁcant
increase of methanol in the breath (and by inference in the
blood) of humans(105) to a level similar to that seen following
the consumption of alcohol spirits(106).
Effects of pre- and probiotics. In vitro studies of isolated
bacterial cultures have demonstrated that the VOC proﬁle
that they produce is distinctive, and may be used to
differentiate bacterial species(107). Whilst some of these
molecules, for example ethanol and acetone, are produced
by their human host, other trace gases, for example H2 and
indole, are only produced in detectable quantities by
bacteria(107). Furthermore, the gases emitted by bacteria also
appear to be dependent on the strain of the bacterial
isolate(108) and culture conditions(109). Bartram et al.(110) have
reported that daily yogurt enriched with Biﬁdobacterium longum
and 5 g lactulose/l increased breath H2 exhalation and
mouth-to-caecum transit time.
SCFA are produced by bacterial fermentation of carbo-
hydrates in the colon, inﬂuence gastrointestinal motility(111),
and can affect motility at a distance from their site of pro-
duction. The mechanisms of action of SCFA on gastrointesti-
nal motility have not been completely elucidated. They may
involve systemic humoral and neural pathways as well as
local reﬂexes and myogenic responses.
Cellobiose has a β-1,4 linkage, so it is resistant to hydrolysis
by human small-intestinal disaccharidase and, hence, reaches
the colon undigested. The excretion of breath H2 gas after cel-
lobiose ingestion was found to be signiﬁcantly greater than
after glucose ingestion(112). In another study, prebiotic treat-
ment increased breath H2 excretion by 3-fold and reduced
hunger(113). The AUC for plasma glucagon-like peptide 1
and the volatile release curve for breath-H2 excretion
measured after the meal were signiﬁcantly correlated with
each other(113).
Dietary micronutrients. Micronutrients have the potential to
affect redox status and prevailing inﬂammation, or they
may have direct effects on constituents within breath.
Furthermore, lung function (forced expiratory volume)
appears to be related to dietary vitamin C(114) and fruit
intake(115), although the latter study was in children and so
the ﬁndings may not be the same for adults. Increased
concentrations of breath alkanes are associated with reduced
antioxidant micronutrient status(45). Supplementation with a
cocktail of antioxidant vitamins (vitamin C, vitamin E and
β-carotene) has been reported to be associated with reduced
breath pentane in smokers(116). In contrast, Fe supplements
have been found to increase breath ethane concentrations in
young women(117). The amount of breath dimethyl selenide
has been reported to increase after the ingestion of Se
supplements(118) and substantial amounts are found in the
breath of individuals with Se toxicity(119), and this may
account for the characteristic breath odour in individuals
with this condition(119).
Principles of measurement
The ability to accurately measure concentrations of trace gases
in humid breath has only been possible in the last 20–30 years.
GC-MS has been used widely used for breath analysis and
continues to be vigorously exploited to great effect for this
purpose. In GC-MS, breath samples are collected and volatile
compounds extracted and pre-concentrated before ofﬂine
analysis. Whilst GC-MS has allowed the identiﬁcation of com-
pounds in breath it is not possible to use this technique in real
time(3,4). It is disturbed by the large amount of water vapour
present in humid exhaled breath.
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More recent analytical advances include SIFT-MS, proton
transfer reaction (PTR)-MS and various optical spectroscopic
or electronic ‘nose’ devices; these are techniques that have
allowed real-time analysis of breath(120–123). Spectroscopic
detection methods have been designed to detect speciﬁc
simple molecules of permanent gases, such as NO and
ethane(121) rather than a proﬁle of VOC in breath, but are
amenable to real-time applications. The physicochemical prin-
ciple of electronic nose devices is that exposure of the detector
to speciﬁc compounds is associated with a change in surface
conductivity of the sensor; however, interpretation may be
complicated for humid samples(123) and they generally lack
positive identiﬁcation.
Methods commonly used for breath analysis
Those methods used for breath analysis mentioned above are
brieﬂy described below and summarised in Table 2. The most
widely reported breath analytes are shown in Table 3, together
with the methods used to detect them, their concentrations,
sources and potential confounding factors.
Ion mobility spectrometry
The aim of ion mobility spectrometry is to identify trace gases
by the mobility of their characteristic gas-phase ions or their
derivatives in a buffer/carrier gas(124). These ions are pro-
duced by exposing the carrier gas/trace gas to a radioactive
source or electrical discharge when chemical ionisation reac-
tions result in the analytical drifting ions. The movement of
these ions is dependent on their mass and molecular geometry,
and their dwell times are used to characterise the original mix-
ture of trace gases. Whilst this approach is not recommended
for the identiﬁcation of unknown compounds, it has been
used to determine differences in breath metabolite proﬁles
associated with speciﬁc diseases(123).
Proton transfer reaction-MS and proton transfer
reaction-time of flight
In these techniques, precursor hydronium ions (H3O
+) are
injected into the buffer gas, which is usually the gas sample
to be analysed, and react with the trace gas present in the
sample. The precursor ions react with the trace gas species,
producing characteristic ion products that are detected and
quantiﬁed using a down-stream analytical MS. PTR-MS is sen-
sitive down to and below ppbv(125–127). The precursor mol-
ecules react with most trace gas molecules to produce a
protonated molecule (MH+). However, the latter nascent ion
may be unstable for some compounds, for example, when
M is an alcohol. Furthermore, when the carrier gas in
PTR-MS is humid breath, this leads to the formation of cluster
ions, for example H3O
+·(H2O)1,2,3 that may make quantitative
analysis more complex, although this cluster ion formation is
inhibited by the presence of the axial electric ﬁeld along the
ﬂow tube(128). In PTR-time-of-ﬂight analysis, ions are acceler-
ated to uniform energy by an electric ﬁeld, and subsequently
traverse a deﬁned distance. The time of ﬂight of the ion is
directly related to the ion’s mass:charge ratio, and this allows
a mass resolution that is substantially better than for conven-
tional PTR-MS(129). Whilst the original instruments relied on
long integration times to attain sufﬁcient sensitivity, recently
developed PTR-time of ﬂight instrumentation has improved
sensitivity(130), with integration times of 1 s and a correspond-
ing limit of detection approaching 100 parts per trillion for
most compounds, allowing online breath analysis(129).
Table 2. Summary of methods used for breath analysis
Method Principle References
GC Sample injected onto a chromatographic column using an inert gaseous
mobile phase. The column may be polar or non-polar. The separated
compounds are then detected by MS, flame ionisation or ion mobility
spectrometry
Phillips(3), Sanchez & Sachs(153)
PTR-MS and PTR-TOF VOC are ionised by their reaction with H3O
+. Can be performed without
pre-concentration, and can be undertaken online. Compounds identified
by mass:charge ratio of characteristic ions, isomers cannot be differentiated
by PTR-MS and therefore may require further characterisation. Recent
PTR-TOF methods have substantially improved mass resolution and are
sensitive down to parts per trillion
Moser et al.(125), Lirk et al.(126), Blake
et al.(128), Herbig et al.(129)
SIFT-MS VOC are introduced at a controlled rate and reacted with a precursor ion
(H3O
+, NO+ or O2
+) in a reaction (flow) tube. The product ions are analysed by
quadrupole MS. This technique is sensitive down to parts per billion by
volume in real time and online, and has good intra-individual repeatability
Smith & Španěl(120,155,156), Wang(131),
Smith et al.(11,154), Boshier et al.(157)
Chemical sensors
(noses)
This method relies on the use of chemical sensors, often arranged as arrays,
and linked to a data analysis system for chemical fingerprint analysis with
reference to a database
Thaler et al.(134), Oh et al.(158)
Chemiluminescence This can be used if the trace gas reacts with ozone to generate a
chemiluminescence signal which can be measured using a
photomultiplier tube
Toda & Dasgupta(136)
Optical and laser
spectroscopy
Absorbance spectroscopy of the trace gas is assessed using a laser light
source in the mid-IR range. Recent improvements in the technique have
allowed it to be applied to the real-time measurement of a number of
potentially important trace gases including NH3, ethane and NO
Wang & Sahay(121), McCurdy et al.(122),
Lewicki et al.(159), Dahnke et al.(160)
PTR, proton transfer reaction; TOF, time of flight; VOC, volatile organic compounds; SIFT, selected ion flow tube.
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Table 3. Summary of breath analytes with reported ranges and sources
Compound Study Number of subjects Method Concentration (ppbv) Source Comments
Acetaldehyde Diskin et al.(22) 5 SIFT-MS Range 2–5 Ethanol metabolism(90) Oral microbes
Liver
Fuchs et al.(161) 12 lung cancer
patients
12 smokers
12 healthy
volunteers
GC-MS Lung cancer:
mean >200
Carbohydrate metabolism,
ambient air
No significant difference in
exhaled acetaldehyde concentrations
in all subject groups
Turner et al.(27) 30 SIFT-MS Mean 24 (range 0–
104)
Ethanol metabolism Increased levels detected with
consumption of sweet drinks/food
2 h before
Acetone Turner et al.(24) 30 SIFT-MS
H3O +O2
+
Mean 477 (range 148–
2744)
Decarboxylation of
acetoacetate, dehydrogenation
of isopropanol
Levels strongly influenced by physiological
factors other than diet
Smith et al.(26) 6 SIFT-MS Pre-meal: range 200–
600
5 h Post-meal: mean
about 200
Related to blood glucose in
some studies(162)
NH3 Diskin et al.
(22) 5 SIFT-MS
H3O +O2
+
Range 422–2389 Protein metabolism(163) Not much day-to-day variation in
individuals
Turner et al.(24) 30 SIFT-MS Mean 833 (range 248–
2935)
Protein metabolism Breath concentrations influenced by age
and background air
Španěl
et al.(163)
6 SIFT-MS Range 200–1750 Protein diet
Smith et al.(26) 6 SIFT-MS Pre-meal: range 300–
600
5 h Post-meal: range
600–1800
Allyl sulfides Rosen et al.(164) Simulated Thermal desorption GC-MS Garlic(165,166) Allicin decomposes in gastric acid leading
to the formation of allyl sulfides(167)
Carbon
disulfide
Phillips(168) 42 GC-MS Range 0·005–0·008 Atmospheric(168)
Ciaffoni
et al.(169)
Laser absorption spectroscopy Gut bacteria(170)
Carbonyl
sulfide
Wysocki
et al.(171)
Simulated Pulsed quantum cascade-based
sensor
Gut bacteria(170)
Halmer
et al.(172)
Simulated Mid-cavity leak out spectroscopy
CO Middleton &
Morice(173)
65 Electronic nose device Non-smokers: mean
1830
Smokers: mean 17400
Haem catabolism(174) Formation catalysed by hame
oxygenase(175) and CO production is
increased by haemolysis(174)
Paredi et al.(176) 37 Electrochemical Non-diabetics: mean
2900
Diabetics: range
4–5000
Costello
et al.(177)
10 Electrochemical detector Non-smokers:
mean 2100
(range 600–4900)
Smokers: mean 12800
(range 8300–18700)
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Dimethyl
sulfide
Tangerman
et al.(178)
GC Normal: mean 7·6
(SD 0·6)
Cirrhotics: mean 41
(SD 11·5)
Methionine metabolism Production is dependent on intestinal
bacteria(170)
Azad et al.(179) Simulated Chemiluminescence
Ethane Paredi et al.(180) 22 GC Mean 0·88 Lipid peroxidation(46,48,50) The production of ethane and pentane is
dependent on antioxidant status(181,182)
Ethanol Diskin et al.(22) 5 SIFT-MS
H3O
+
Mean 196
(range 0–474)
Gut flora
Smith et al.(26) 6 SIFT-MS Range 55–121
Ethylene Dumitras
et al.(183)
1 non-smoker
1 smoker
Photo-acoustic spectroscopy Mean 20 Lipid peroxidation(46,48–50)
H2 Perman
et al.(184)
221 children
9 adults
GC with electrochemical detection Mean 7100 Carbohydrate metabolism(81,85) Formed by hydrolytic and saccharolytic
bacteria(185)
Costello
et al.(177)
10 Electrochemical detector Mean 9100 (range
300–34000)
Large within-individual variation
Hydrogen
cyanide
Schmidt
et al.(28)
19 Cavity ring down spectroscopy Range 1·3–6·5 Oxidation of thiocyanate by
peroxidase(186)
Španěl
et al.(187)
26 SIFT-MS Mean 8
Enderby
et al.(188)
16 children with
cystic fibrosis
21 children with
asthma
SIFT-MS Mean 13·5
Mean 2·0
Derived from Pseudomonas
aeruginosa(188)
Hydrogen
sulfide
Costello
et al.(177)
10 Electrochemical detector Mean 330 (range
0–1300)
Oral flora
Isoprene Turner
et al.(23,30)
20 SIFT-MS
NO+
Mean 118 (range
0–474)
Cholesterol metabolism(189,190) Exercise(190)
Age
Haemodialysis
Statin therapy(191)
Jones et al.(192) 16 Thermal desorption GC and diode
array UV detection
Range 36–231 Cholesterol metabolism(189,190) No statistical difference in isoprene
concentrations between men and women
Smith et al.(25) 200 SIFT-MS Range 28–54 Age dependent
Davies
et al.(193)
19 SIFT-MS Mean 89 (SD 36)
Taucher
et al.(194)
PTR-MS Range 100–1000 Children <6 years had values less than
adults
Methane Dryahina
et al.(195)
75 SIFT-MS
O2
+
Range 6–30 Carbohydrate metabolism(196–
198)
Most produced by Methanobrevibacter
smithii which uses H2 to reduce CO2
(199)
Methanol Turner et al.(23) 30 SIFT-MS
H3O
+
Median 461 (range 32–
1684)
Fruit metabolism(105) Inversely related to BMI
Fruit and alcohol
Taucher
et al.(106)
PTR-MS Mean 400
Methylamine Marinov
et al.(200)
Simulated Near-IR laser spectrometer based
on the cavity ring down detection
Protein metabolism
Methyl nitrate Novak et al.(201) 10 T1DM
children
GC offline using electron
capture(201)
Range 0·005–0·010 Oxidative processes Correlation with blood glucose
Methyl
mercaptan
Chen et al.(170) Methionine metabolism(170)
NO Paredi
et al.(202,203)
Chemiluminescence, following its
reaction with O3
(204)
Mean 6·7 NO synthase and
arginine(205–208)
Concentration is dependent on
exhalation flow rate(209)
Continued
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Selected ion flow tube-MS
SIFT-MS combines the fast ﬂow tube technique, chemical ion-
isation using selected precursor ions, either H3O
+, NO+ or
O2
+, and quantitative MS that allows online, real-time quanti-
tative analysis of the trace gases (such as ethanol, acetaldehyde,
NH3, acetone and isoprene, etc.) in single breath exhalations
down to concentrations in the ppbv range in a timescale of
seconds(131). SIFT-MS relies on chemical ionisation by the
chosen precursor ions of the trace gas molecules in air/breath
samples introduced into He carrier gas. These reactions pro-
ceed for an accurately deﬁned time, the precursor and product
ions being detected and counted by a downstream quadrupole
mass spectrometer, thus effecting quantiﬁcation. Because the
absolute concentrations of trace gases in single breath exhala-
tion can be determined by SIFT-MS down to ppbv concen-
trations, this obviates the need for ofﬂine sample collection
for the most common breath trace gases. A numerical algor-
ithm allows the calculation, in real time, of absolute concen-
trations of trace gases, including VOC and water vapour(132).
Optical and laser spectroscopic detection
Laser spectroscopic detection techniques have high sensitivity
and high selectivity, but also have the advantageous features of
near real-time response and low instrument cost. Of approxi-
mately thirty-ﬁve biomarkers quantiﬁed using this method,
fourteen species have been analysed in exhaled human breath
by high-sensitivity laser spectroscopic techniques, for example
acetone, NH3, CO2, ethane, CH4 and NO. The spectral ﬁnger-
prints of these potentially useful biomarkers span from the
UV to the mid-IR spectral regions and the detection limits
achieved by the laser techniques range from parts per million
by volume to ppbv. Sensors using the laser spectroscopic tech-
niques are already commercially available for a few breath bio-
markers, for example CO2 and NO
(121).
Electronic nose detection
Electronic noses, or artiﬁcial sensors of volatiles including
odorants, have been developed over the last 10 years to perform
a variety of identiﬁcation tasks in various industries. Electronic
noses produce a chemical ﬁngerprint of the sample, and this is
matched to a reference database(133). This powerful technology
is only beginning to be introduced in the ﬁeld of medicine,
but is promising in its potential to assist in diagnosis(134).
Chemiluminescence
Chemiluminescence (CL) is a powerful analytical tool in trace
gas analysis. CL monitoring has been used as universal nitro-
gen and sulfur detectors for GC and capillary electrophor-
esis(135). CL detection can be used as the basis of compact
and sensitive analysers for real-sample analysis. Isoprene and
sulfur compounds in expired breath and atmospheric samples
have been successfully measured by coupling to a small collec-
tion system. Short-term adsorbent collection enhances the sensi-
tivity and considerably reduces interference. The organosulfurTa
b
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compounds methyl mercaptan and dimethyl sulﬁde can be sep-
arated on the same column that is used for collection(136).
Conclusions
Breath analysis is becoming more accessible for clinical and
physiological applications. Expired breath is a complex mix-
ture of low-molecular-weight volatile compounds that are
derived from diet and endogenous metabolism, or from
micro-organisms in the gastrointestinal and respiratory tracts.
Metabolic, inﬂammatory and neoplastic conditions are
reported to be associated with characteristic breath proﬁles,
and breath analysis has been promoted as a potentially simple,
non-invasive method for screening and monitoring conditions
such as asthma, diabetes mellitus and lung cancer. However,
there are a number of factors that affect the concentrations
of compounds in breath, including diet, physical activity and
smoking habit, and it will be important to better understand
how these factors inﬂuence breath composition as the appli-
cations of breath analysis broaden in scope. In order to
apply breath analysis to investigations of human nutrition,
it would be important to consider any concomitant
co-morbidity, including renal and liver dysfunction, neoplastic
disease, infection and inﬂammation. Breath sampling should
probably take place under standardised conditions, for
example after an overnight fast, and involve diurnal and longi-
tudinal monitoring. A method should be used that is less sen-
sitive to the local release of compounds from the oral cavity.
Whichever methods are used should probably also have
deﬁned age-related reference ranges.
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